Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cysteine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL28238218 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL1573764 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL18160 | 1.00 | — | — | |
| Cysteine SCHEMBL1573765 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL50242 | 1.00 | — | — | |
| Cysteine SCHEMBL17394843 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL16894009 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL16894007 | 1.00 | PTGS1 (0.94) | — | |
| Cysteine SCHEMBL50241 | 1.00 | — | — | |
| Cysteine SCHEMBL7610984 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120081854-A | Method for preparing cefminox sodium through continuous flow | 山东安弘制药有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-115372341-B | Bioluminescence detection system of bacterial cell wall neopeptidoglycan constructed by D-lysine derivative and application method | 西北工业大学深圳研究院 | 2025-04-25 | — | — | CN | claimed |
| CN-119707858-A | High-purity D-luciferin substance and preparation method and application thereof | 生工生物工程（上海）股份有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119462692-A | Cefmorium rice method for synthesizing noro | 山东安弘制药有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119409656-A | Bioluminescence probe (ZD-1) for detecting butyrylcholinesterase in organism and preparation method and application thereof | 四川大学华西医院 | 2025-02-11 | — | — | CN | claimed |
| CN-119390665-A | Compound for detecting carboxylesterase 2 in living body, or salt or stereoisomer thereof, and preparation method and application thereof | 四川大学华西医院 | 2025-02-07 | — | — | CN | claimed |
| CN-119118948-A | Two with tyrosinase inhibitory activity hydroxybenzaldehyde half cystine condensate | 中国科学院昆明植物研究所 | 2024-12-13 | — | — | CN | claimed |
| CN-118630218-B | Sodium ion oxide positive electrode material, preparation method thereof and vehicle | 浙江华宇钠电新能源科技有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-118630218-A | Sodium ion oxide positive electrode material, preparation method thereof and vehicle | 浙江华宇钠电新能源科技有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-115888656-B | Hydrothermal synthesis method of metal organic framework Cys-MIL-101 adsorbent | 四川轻化工大学 | 2024-07-12 | — | — | CN | claimed |
| CN-102485232-A | Medicinal composition containing decitabine | SUZHOU KENAIER MEDICAL TECHNOLOGY CO LTD | 2012-06-06 | — | — | CN | claimed |
| CN-102432413-A | Purification method for improving chiral purity of D-amino acid | UNIV CHONGQING POSTS & TELECOM | 2012-05-02 | — | — | CN | claimed |
| US-20120095041-A1 | REVERSIBLE NONDEPOLARIZING NEUROMUSCULAR BLOCKADE AGENTS AND METHODS FOR THEIR USE | CORNELL UNIVERSITY (US) | 2012-04-19 | — | — | US | claimed |
| CN-102321100-A | Preparation method of cefminox sodium | HAINAN XINZHONGZHENG PHARMACEUTICAL CO LTD | 2012-01-18 | — | — | CN | claimed |
| CN-102260279-A | Raw material of cephalo-type medicines and preparation method thereof | — | 2011-11-30 | — | — | CN | claimed |
| CN-102260132-A | Demethylating reagent, method for removing methyl and method for preparing luciferin by use of demethylating reagent | — | 2011-11-30 | — | — | CN | claimed |
| CN-101696214-B | Cefminox sodium compound of new route | HAINAN MEIDA PHARMACEUTICAL CO | 2011-02-02 | — | — | CN | claimed |
| WO-2010107488-A1 | REVERSIBLE NONDEPOLARIZING NEUROMUSCULAR BLOCKADE AGENTS AND METHODS FOR THEIR USE | CORNELL UNIVERSITY (US) | 2010-09-23 | — | — | WO | claimed |
| CN-101696214-A | Cefminox sodium compound of new route | HAINAN MEIDA PHARMACEUTICAL CO | 2010-04-21 | — | — | CN | claimed |
| CN-101475518-A | Preparation of expectorant mecysteine hydrochloride raw material L-2-amino-3-mercaptopropionic acid methyl ester hydrochloride | XIUZHENG PHARMACEUTICAL GROUP (CN) | 2009-07-08 | — | — | CN | claimed |